Seeking Alpha

Mallinckrodt, Cadence soar following M&A deal

  • Mallinckrodt (MNK) is +8% and Cadence (CADX) +26% following news that Mallinckrodt has agreed to acquire Cadence for $1.3B.
  • The deal will increase Mallinckrodt's specialty pharmaceutical offerings and its presence in hospitals, where Cadence's products are widely used. These include Ofirmev, an intravenous painkiller and fever reducer with estimated 2013 sales of $110.5M in 2013.
  • Mallinckrodt expects the transaction to be immediately accretive to its 2014 earnings and significantly accretive to income a year later.
  • Mallinckrodt plans to finance the transaction through a senior secured term loan facility.
  • Previous
Comments (1)
  • 50 cent it is
    , contributor
    Comments (1284) | Send Message
    How many times to you seethe stock price of the acquiring co go up?
    Not many
    Nice transaction MNk
    11 Feb, 10:36 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: